《Epma Journal》雜志的最新年發文量為39篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在醫學：研究與實驗領域的學術影響力。
該刊聚焦于醫學-醫學：研究與實驗領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 。
Epma Journal 雜志發文統計
文章名稱引用次數
- The crucial role of multiomic approach in cancer research and clinically relevant outcomes48
- Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles28
- Preventive, predictive, and personalized medicine for effective and affordable cancer care23
- Identification of clinical trait-related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer19
- Plant natural modulators in breast cancer prevention: status quo and future perspectives reinforced by predictive, preventive, and personalized medical approach16
- Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy15
- Signaling pathway network alterations in human ovarian cancers identified with quantitative mitochondrial proteomics14
- Dry mouth and Flammer syndromes-neglected risks in adolescents and new concepts by predictive, preventive and personalised approach14
- Pregnancy-associated breast cancer: the risky status quo and new concepts of predictive medicine14
- Diabetes care in figures: current pitfalls and future scenario14
國家/地區發文量
- GERMANY (FED REP GER)32
- CHINA MAINLAND30
- USA22
- Czech Republic13
- Australia11
- Russia7
- South Korea7
- Slovakia6
- Switzerland6
- Belgium5
